NCT06144957View on ClinicalTrials.gov

SLC13A5 Deficiency Natural History Study - United States Only

Enrolling by invitationOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Citrate Transporter DeficiencyEpilepsyRare DiseasesMovement DisordersGenetic DisorderSLC13A5 DeficiencyEIEE25Kohlschutter-Tonz Syndrome (Non-ROGDI)Citrate Transporter DisorderDEE25
Trial Locations (3)

75390

University of Texas Southwestern Dallas, Dallas

94304

Lucille Packard Children's Hospital, Stanford University, Palo Alto

02903

Brown University, Providence

Sponsors

Collaborators (1)

Brown University
All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

Brown University

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

lead

TESS Research Foundation

OTHER

NCT06144957 - SLC13A5 Deficiency Natural History Study - United States Only | Biotech Hunter | Biotech Hunter